The Effects of Drug Regulation: A Systematic Analysis

  • M. N. G. Dukes
  • Inga Lunde
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 39)


Although almost all the countries of Europe, during the present century, have introduced regulatory systems to ensure that new drug and drug products entering the market are efficacious and safe, and manufactured and sold in a responsible fashion, the nature and extent of experience vary quite widely. Some are liberal, others extraordinarily restrictive; a few have operated for decades, whilst others are still in their infancy.


Drug Control Internal Parameter Drug Regulation Regulatory Practice Sufficient Justification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M.N.G. Dukes and I. Lunde, Controls, common sense and communities, Pharm. Weekly Bulletin, 114: 1283–1294 (1979).Google Scholar
  2. 2.
    M.N.G. Dukes and I. Lunde, Measuring the repercussions of drug control: An emerging challenge, Pharm. J. 223: 511–513 (1979).Google Scholar
  3. 3.
    I. Lunde and M.N.G. Dukes, Les repercussions du controle administratif des medicaments (text in French and English), Ind. sante 49: 37–57 (1980).Google Scholar
  4. 4.
    M.N.G. Dukes and I. Lunde, The regulatory control of nonsteroidal anti-inflammatory agents, Eur. J. Clin. Pharmacol. 19: 3–10 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    I. Lunde and M.N.G. Dukes, Drug regulation and the concept of geriatric drugs. Presented at the Ninth European Symposium on Clinical Pharmacological Evaluation in Drug Control, Schlangenbad, 18–21 November 1980, arranged by World Health Organization, Regional Office for Europe.Google Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • M. N. G. Dukes
    • 1
  • Inga Lunde
    • 2
  1. 1.Department of Pharmacotherapy, Central Inspectorate for DrugsNetherlands Ministry of HealthThe Netherlands
  2. 2.Pharmacotherapy DepartmentDrug Products Control CentreNorway

Personalised recommendations